Evidence map›Paper›PMID 38573823›Full record

ArticleJournal of industrial microbiology & biotechnology2024

Application of the surface engineered recombinant Escherichia coli to the industrial battery waste solution for lithium recovery.

Jaehoon Jeong, Vidhya Selvamani, Murali Kannan Maruthamuthu, Kulandaisamy Arulsamy, Soon Ho Hong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jaehoon JeongDepartment of Chemical Engineering, University of Ulsan, Namgu, Ulsan 44610, Republic of Korea.
Vidhya SelvamaniDepartment of Chemical Engineering, University of Ulsan, Namgu, Ulsan 44610, Republic of Korea.
Murali Kannan MaruthamuthuDepartment of Chemical Engineering, University of Ulsan, Namgu, Ulsan 44610, Republic of Korea.
Kulandaisamy ArulsamyDepartment of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India.
Soon Ho HongDepartment of Chemical Engineering, University of Ulsan, Namgu, Ulsan 44610, Republic of Korea.ORCID 0000-0003-0035-7117
University of Ulsan · KRIndian Institute of Technology Madras · IN

Funding

Korea Institute for Advancement of Technology P0023727National Research Foundation of Korea
6 · The paper itself

Abstract

Escherichia coli were engineered to selectively adsorb and recover lithium from the environment by employing a bacterial cell surface display strategy. Lithium binding peptide (LBP1) was integrated into the Escherichia coli membrane protein OmpC. The effect of environmental conditions on the adsorption of lithium by a recombinant strain was evaluated, and lithium particles on the cellular surface were analyzed by FE-SEM and XRD. To elevate the lithium adsorption, dimeric, trimeric, and tetrameric repeats of the LBP1 peptide were constructed and displayed on the surface of E. coli. The constructed recombinant E. coli displaying the LBP1 trimer was applied to real industrial lithium battery wastewater to recover lithium.

Indexed as

Escherichia coliLithiumPorinsAdsorptionBacterial Outer Membrane ProteinsCell Surface Display TechniquesElectric Power SuppliesEscherichia coli ProteinsIndustrial WasteRecombinant ProteinsWastewaterBacterial Outer Membrane ProteinsEscherichia coli ProteinsIndustrial WasteLithiumOmpC proteinPorinsRecombinant ProteinsWastewaterBattery wastewaterEscherichia coliLithiumMetal binding peptide

Identifiers

PMID38573823
PMCPMC11037431
OpenAlexW4393929737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.